6,402 Shares in The Clorox Company $CLX Acquired by Tred Avon Family Wealth LLC

Tred Avon Family Wealth LLC bought a new stake in The Clorox Company (NYSE:CLX – Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 6,402 shares of the company’s stock, valued at approximately $663,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CLX. Vermillion & White Wealth Management Group LLC acquired a new position in shares of Clorox in the 3rd quarter worth approximately $25,000. Caitlin John LLC increased its position in shares of Clorox by 1,807.1% during the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after buying an additional 253 shares during the period. Darwin Wealth Management LLC bought a new position in Clorox during the second quarter worth $29,000. Vision Financial Markets LLC raised its stake in Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after buying an additional 200 shares during the last quarter. Finally, SHP Wealth Management acquired a new position in Clorox in the fourth quarter valued at $35,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Get Clorox alerts:

Insiders Place Their Bets

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.63% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. Morgan Stanley decreased their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. Royal Bank Of Canada dropped their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. The Goldman Sachs Group restated a “sell” rating and set a $83.00 target price on shares of Clorox in a research report on Friday, May 1st. UBS Group decreased their target price on Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a research note on Friday, May 1st. Finally, Weiss Ratings upgraded Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus target price of $103.40.

View Our Latest Stock Analysis on Clorox

Clorox Trading Down 0.0%

Shares of Clorox stock opened at $97.51 on Monday. The stock has a market capitalization of $11.79 billion, a PE ratio of 15.83, a price-to-earnings-growth ratio of 0.51 and a beta of 0.56. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $132.03. The stock has a 50 day moving average price of $94.67 and a two-hundred day moving average price of $104.45. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84.

Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the firm earned $1.45 earnings per share. Clorox’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Articles

• Five stocks we like better than Clorox
• As Stablecoins Keep Growing, These 2 Stocks Benefit
• Apple Just Handed These 4 Memory Stocks Their Best News of the Year
• Costco’s Secret Growth Engine May Be Running Out of Gas
• Why Alphabet’s Pullback May Be an Opportunity in Disguise

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.